Mobile Application Study for Mild Cognitive Impairment and Mood Symptoms

  • STATUS
    Recruiting
Updated on 29 June 2022
Investigator
Katie Rodammer
Primary Contact
Click Therapeutics (online study) Contact
cognitive impairment
Online studies

Summary

This is a randomized, virtual, basket study to evaluate the initial effects of a mobile application as compared to a care-as-usual control group on cognitive functioning and mood symptoms in adult participants with MCI. The study consists of an up to 14-day screening period, 3-week randomized intervention period, and 7-10 day follow-up period. All study activities can be completed from your phone and computer, there is no placebo, and participants don't need to start or withdraw from medications.

Home page:

Description

Screening Period (up to 2 weeks): All participants will enter an online screening period of up to 14 days to determine eligibility and sign informed consent. Screening and Baseline may occur on the same day if all required assessments have been completed per the protocol. Baseline Visit (Day 1): Approximately 40 eligible participants will be enrolled during a virtual study visit on Day 1. Participants will be randomized 1:1 (Study App:care-as-usual control group). Assessments will occur according to the Schedule of Activities and Assessments (SoA). Intervention Period (3 weeks): Participants randomized to the Study App group will download and activate the Study App onto their personal primary iPhone or Android smartphone, and will be directed to access and perform tasks every day as directed by the Study App. Participants in the control group will not receive any study intervention and will resume their usual MCI treatment. Assessments will occur for both the Study App and control groups according to the Schedule of Activities and Assessments. Follow-Up Period (1 week): Participants will complete follow-up assessments according to the SoA. Participants randomized to the Study App group will not perform any activities within the application.

Details
Condition Dementia, Mild Cognitive Impairment
Clinical Study IdentifierTX298567
Last Modified on29 June 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note